Svenska                Glossary                Search    
 
 
AboutTechnologyProjectInvestorMedia Releases 2010Contact
 
 
 
 

Site Policy

Neuronova AB may monitor your access to this Website. If monitored, the requesting URLs, IP address of the machine originating the request and time of request are logged for access statistics and security purposes. By using and accessing the Website you are agreeing to such general monitoring. Nothing in this Privacy policy is intended to protect the privacy of Users whose use of the Website is, in our reasonable judgment, intended for illegal, improper or abusive purposes or for purposes of marketing or solicitation, or would violate any other terms and conditions relating to the use of the Website. NeuroNova AB will cooperate with law enforcement agencies in identifying those who use NeuroNova AB's services for illegal activities. NeuroNova AB reserves the right to report to law enforcement agencies any activities that the Company believes in good faith to be unlawful. The User agrees that use of the Website is on an "as is" basis and without express or implied warranty of any kind. The User assumes all responsibility and risk for using or viewing the Website and all Website content, including but not limited to all text, data, files, tools, pages and features of any kind (the "Content").

Copyright

The Content displayed on the Website is the property of NeuroNova AB and is protected by copyright and other intellectual property laws. Website Use Terms and Conditions Unless expressly authorized in writing, copying, distribution, modification or reproduction of the Content is strictly prohibited. Using the Content without permission may result in a violation of copyright or trademark law, and could infringe portrait or privacy rights. You may view, download and print the documents and information available on the Website, only with indication of the source, for personal, non-commercial or home use but you may not modify any documents or information nor remove any copyright or other proprietary notices contained in the documents.

 

   
© NeuroNova AB, Sweden, Tel: +46 (0)8 786 0900, Email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it  
Sitemap Site policy 
 
 
Project Pipeline

Project

    Indication  

Pre-clin.

   IND  

 Phase I/II

 Phase II

 Phase III 

sNN0029ALS      
sNN0031Parkinson's disease     
More about our ProjectsImage

 Business Development

NeuroNova’s business strategy centers on developing novel therapeutic products based on neurogenesis in areas of high unmet medical need in neurodegenerative diseases.
More about business development.Image